Life/2021 webinars

about Life/2021 webinars
The unique program of the Life/2021 webinar series includes topics such as optimizing anemia management, improving cardiovascular health and ensuring patient transition to the right therapy at the right time. Review the webinars by clicking the "Play-Button" next to your webinar of choice.
Recent sessions:

Prof. Dr. Christoph Wanner
University Hospital, Würzburg / Germany

Prof. Dr. Peter Stenvinkel
Karolinska University Hospital, Stockholm / Sweden

Prof. Dr. Bernard Canaud
Fresenius Medical Care / France
He has published 400 peer-reviewed manuscripts, contributed to more than 80 textbook chapters and attended more than 1000 scientific medical meetings. Prof. Canaud has received several awards and distinctions from international nephrology societies including the prestigious Belding Scribner award from the ISHD in 2010. He also received the “Légion d’Honneur” as recognition for his lifetime of medical achievement from the French president in 2009. In March 2019, the ADC and Missouri University, USA, awarded him for his lifetime achievement in nephrology and commitment to renal replacement therapy.

Dr. Franklin W. Maddux
Fresenius Medical Care, North Amercia / United States

Dr. Natalie Borman
Queen Alexandra Hospital, Portsmouth / United Kingdom

Dr. Allan J. Collins
Fresenius Medical Care, USA / United States

Prof. Dr. Francesca Mallamaci
Bianchi-Melacrino-Morelli Hospital, Reggio Calabria / Italy

Giovanni Tripepi
CNR-IFC Research Unit of Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension of Reggio Calabria / Italy
Dr Giovanni Luigi Tripepi is born in Reggio Calabria, Italy. In 2005, he achieved the university degree in Biostatistics at the Messina University, Italy. On August 2009 and September 2012, he achieved the Master of Science in Epidemiology and the PhD in Clinical Epidemiology, respectively, at the Erasmus University of Rotterdam, Netherlands. He is a Biostatistician/ Epidemiologist with experience in teaching and research in the field of clinical epidemiology and medical statistics.
He is Director of Research at the CNR-IFC Research Unit of Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension of Reggio Calabria, Italy. Dr. Tripepi is co-author of 400 articles published in international peer-reviewed journals. His H-index is 71.
Dr Tripepi is component of the Editorial Board of Nephrology, Dialysis and Transplantation and Blood (Statistical Consultant). He also belongs to the Top Italian Scientist of VIA Academy.

Dr. Charles Chazot
NephroCare, France / France
From 2007 to 2013 he was a Medical Director and General Manager of the Tassin Dialysis Unit that belongs to Fresenius Medical Care since 1998. He has a Master’s degree in Management of Healthcare Units.
Dr. Chazot is currently NephroCare country medical director for France. His special interests are in the fields of nutrition, extra-cellular volume and blood pressure controls in dialysis patients.
Dr. Chazot has published 140 peer-reviewed papers, 3 book chapters and is a regular reviewer for nephrology journals.
He has been an investigator in the FINE study, Renilon study and GSK HIF study.

Jule Pinter
University of Wuerzburg, Wuerzburg / Germany
Dr Jule Pinter is an Internal Medicine and Nephrology senior medical resident and pursues a German Research Foundation supported clinician-scientist track at the University of Wuerzburg.
She has been a medical registrar and clinical lecturer at the University Hospital Wuerzburg, Germany. Prior to this, she started her research in prestigious electives at known research institutes such as McMaster University and the University of Sydney. She graduated from Witten/Herdecke Private University, and worked across different health care systems from Meiringen in Switzerland to Ohio, Cleveland.
Jule’s clinical and research interest lies at the intersection of cardiovascular and kidney disease; she is currently involved in the conduct of both large-scale clinical trials and analyses of observational studies using routinely collected registry data. She has published 10 peer-reviewed articles and conference proceedings, including work featured in The Clinical Journal of American Society of Nephrology, American Journal of Kidney Diseases and Nephrology, Dialysis and Transplantation. In addition, she has a particular interest in qualitative research and health care systems research.
Her dissertation on the perspectives of elderly kidney transplant recipients was recognized with magna cum laude. The clinician-scientist grant awarded by the German Research Foundation allows her to combine structured residency with clinical research.
She is a mentee of the NephroFuture class at the German Society of Nephrology, and is a member of the European Renal Association.
She hopes to improve the lives of people living with kidney disease by working as a nephrologist, and clinical trialist, undertaking high-impact research that develops and disseminates scalable health solutions across the world.

Prof. Dr. Dick de Zeeuw
University Groningen, Groningen / Netherlands

Prof. Dr. Jeroen P. Kooman
University Medical Center, Maastricht / Netherlands
Jeroen Kooman received his medical training at the University of Maastricht in 1990 (MSc and MD cum laude) and received his Ph.D. title in 1992. He was trained in internal medicine and nephrology in the Maxima Medical Centre (formerly St. Joseph Hospital) and the University Hospital Maastricht, the Netherlands. His main research interests comprise, among others, the pathophysiology of systemic complications related to chronic renal failure and end-stage renal disease, the pathophysiology, and consequences of alterations in fluid status and body composition in patients with renal failure, the effect of dialysis therapies on the cardiovascular and nutritional state, as well as the quality of life of patients with renal failure, physical (in)activity in patients with renal failure and the implementation of technical devices to improve physical activity levels, the value of the implementations of technological innovations in the treatment of patients with renal failure and (premature) biological aging in patients with renal disease.

Dr. Len Usvyat
Fresenius Medical Care, North America / United States

Dr. Håkan Hedman
Swedish Kidney Association / Sweden
I am married to my wife Karin and we have a daughter who is 23 years old and who recently graduated with a degree in economics. Two years ago, I retired after working 35 years in the paint industry focusing on ship paints.
As a child, I developed a kidney disease that led to my need for dialysis in adulthood. Since 1985, I have had a kidney transplant after 9 years in dialysis.
I am the President of Swedish Kidney Association and board assignments in two research funds. I also have assignments for the Sahlgrenska Academy at the University of Gothenburg with questions concerning person-centered care and research ethics.
In 2011, I was appointed an Honorary Doctor of Medicine (MD h.c.) at the University of Gothenburg.
I believe that every person has more opportunities to be involved in their care and treatment than is used today. The care provider must listen to the patient's story and see the patient as an equal partner.

Norbert Lameire
University Hospital, Gent / Belgium

Dr. Marie Evans
Karolinska University Hospital, Stockholm / Sweden

Prof. Dr. Kai Lopau
University Hospital, Würzburg / Germany

Dr. Maria F. Slon Roblero
Complejo Hospitalario de Navarra, Department of Nephrology / Spain

Dr. Maxence Ficheux
University Hospital, Caen / France

Prof. Dr. Kitty Jager
University Medical Center, Amsterdam / Netherlands

Raphaël Duivenvoorden
Radboud University Medical Center, Nijmegen / Netherlands
Dr. Duivenvoorden graduted and obtained his Ph.D. at the Academic Medical Center in Amsterdam and Translational and Molecular Imaging Institute of the Icahn School of Medicine at Mount Sinai in New York. He worked on artheroslerosis using nanobiologics in combination with immunomodulatory drugs. He was awarded with the VENI Grant to further explore the utility of HDL-based nanobiologics for innate immune cell targeting in cardiovascular disease. In 2019, he was awarded a Hypatia Tenure Track by the Radboud University Medical Center and in 2020 a Kolff senior post-doc grant by the Dutch Kidney Foundation. Currently, he is focusing on therapeutically modulation of innate immune responses in renal diseases. Dr. Duivenvoorden closely collaborates with the department of the Biomedical Engineering and Imaging Institute at Icahn School of Medicine at Mount Sinai in New York where he holds a position as Adj. Ass. Professor. In addition to leading a research group he performs clinical work as internist-nephrologist and participates in teaching activities for the Curriculum of Medicine (Immunology, bachelor and master phase) at the Radboud university medical center.

Lili Chan
Icahn School of Medicine at Mount Sinai, New York / United States
As a board-certified nephrologist, Dr. Chan is experienced in caring for patients with a variety of renal conditions ranging from acute kidney injury to end stage renal disease while also having a strong interest in research to improve outcomes in patients with chronic kidney disease. In her research, she has utilized large databases of routinely collected information in electronic health records to identify variables associated with adverse outcomes in hemodialysis patients, using advanced computations methods including natural language processing and machine learning..

Prof. Dr. Wim Van Biesen
Ghent University Hospital, Ghent / Belgium

Ariane Zaloszyc
Strasbourg Hautepierre University Hospital, Strasbourg / France
Dr Zaloszyc qualified in Paediatrics at Strasbourg University Medical School. She subsequently trained in paediatric nephrology in the department: Pédiatrie 1 Grands enfants, Hautepierre, Hospital, Strasbourg, under the supervision of Pr Michel Fischbach. She subsequently undertook clinical and research on CKD and dialysis. She is associate professor in the Pediatric’s dpt. Her research interests include studies on peritoneal dialysis in children.

Prof. Dr. Bernard Canaud
Fresenius Medical Care / France
He has published 400 peer-reviewed manuscripts, contributed to more than 80 textbook chapters and attended more than 1000 scientific medical meetings. Prof. Canaud has received several awards and distinctions from international nephrology societies including the prestigious Belding Scribner award from the ISHD in 2010. He also received the “Légion d’Honneur” as recognition for his lifetime of medical achievement from the French president in 2009. In March 2019, the ADC and Missouri University, USA, awarded him for his lifetime achievement in nephrology and commitment to renal replacement therapy.

Prof. Dr. Andrew Davenport
University College London, London / United Kingdom

Prof. Dr. Simon Davies
University Hospitals of North Midlands, Royal Stoke University Hospital, Keele University / United Kingdom

Prof. Dr. Ron Gansevoort
UMC Groningen, Groningen / Netherlands
Ron’s work in the field of CKD and ADPKD has been instrumental in the development of the novel KDIGO and WHO definition and classification of CKD, the development of novel endpoints for RCTs within Nephrology and the first registered treatment for ADPKD. He is committed to getting more attention for screening for early CKD and prevention of CKD progression on a general population level, and specifically for prevention of disease progression in ADPKD . Ron has published over 550 peer reviewed manuscripts and supervised 28 PhD theses. He has been awarded with several prizes and awards, including Fellow of the ASN, Distinguished Fellow of the ERA EDTA, the US Kidney Foundation Distinguished International Medal and the Dutch Society for Nephrology Award. He serves as editor for 5 nephrological journals, and he is a Board Member of the Dutch Society of Nephrology and the European Renal Association.

Prof. Dr. Annette Bruchfeld
Karolinska University Hospital, Stockholm / Sweden

Prof. Dr. Adeera Levin
University British Columbia, Vancouver / Canada

Prof. Dr. Christoph Wanner
University Hospital, Würzburg / Germany

Nadja Grobe
Fresenius Medical Care / United States
Dr. Nadja Grobe received her MS and PhD in Biochemistry from the Martin Luther University Halle Wittenberg, Germany. Prior to joining the RRI in 2017, she gained more than 10 years of experience in guiding and implementing chemistry, biochemistry, and biomedical-focused research in non-profit, academia, and government. As the supervisor of Laboratory Research at the RRI she is applying strategies for improved therapies in nephrology and related fields.

Dr. Peter Kotanko
Renal Research Institute (RRI), New York / United States

Dr. Franklin W. Maddux
Fresenius Medical Care, North Amercia / United States

Dr. Stefano Stuard
Fresenius Medical Care, Germany / Italy